Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Aclaris Therapeutics (ACRS) Return on Assets (2017 - 2025)

Aclaris Therapeutics has reported Return on Assets over the past 9 years, most recently at 0.41% for Q4 2025.

  • Quarterly results put Return on Assets at 0.41% for Q4 2025, up 26.0% from a year ago — trailing twelve months through Dec 2025 was 0.41% (up 26.0% YoY), and the annual figure for FY2025 was 0.36%, up 27.0%.
  • Return on Assets for Q4 2025 was 0.41% at Aclaris Therapeutics, up from 0.8% in the prior quarter.
  • Over the last five years, Return on Assets for ACRS hit a ceiling of 0.21% in Q2 2021 and a floor of 0.8% in Q3 2025.
  • Median Return on Assets over the past 5 years was 0.38% (2024), compared with a mean of 0.42%.
  • Biggest five-year swings in Return on Assets: skyrocketed 31bps in 2024 and later crashed -57bps in 2025.
  • Aclaris Therapeutics' Return on Assets stood at 0.35% in 2021, then increased by 1bps to 0.34% in 2022, then fell by -30bps to 0.45% in 2023, then crashed by -49bps to 0.67% in 2024, then surged by 39bps to 0.41% in 2025.
  • The last three reported values for Return on Assets were 0.41% (Q4 2025), 0.8% (Q3 2025), and 0.71% (Q2 2025) per Business Quant data.